Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-400
Closed -$7K 378
2017
Q4
$7K Buy
400
+25
+7% +$423 ﹤0.01% 474
2017
Q3
$6K Hold
375
﹤0.01% 468
2017
Q2
$6K Buy
375
+50
+15% +$781 ﹤0.01% 478
2017
Q1
$5K Sell
325
-25
-7% -$388 ﹤0.01% 463
2016
Q4
$5K Buy
350
+25
+8% +$384 ﹤0.01% 422
2016
Q3
$5K Hold
325
﹤0.01% 407
2016
Q2
$4K Sell
325
-25
-7% -$348 ﹤0.01% 425
2016
Q1
$5K Buy
+350
New +$4.76K ﹤0.01% 379

Other funds holding IX

Winfield Associates's IX Position: Q1 2018 in Review

Winfield Associates sold out of ORIX (IX) in Q1 2018, closing a stake of 400 shares — an estimated $7K sold.

Winfield Associates first reported a position in IX in Q1 2016 and held it in 8 quarters. The position peaked at $7K in Q4 2017. 158 funds tracked by Wall St. Rank hold IX as of Q1 2018.

  • Winfield Associates reported no remaining ORIX position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 400 ORIX shares in Q1 2018, an estimated $7K.
  • Winfield Associates first reported a position in ORIX in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's ORIX position peaked at $7K in Q4 2017.
  • 158 funds tracked by Wall St. Rank held ORIX as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.